213 related articles for article (PubMed ID: 17581986)
1. Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model.
Chen Z; Earl P; Americo J; Damon I; Smith SK; Yu F; Sebrell A; Emerson S; Cohen G; Eisenberg RJ; Gorshkova I; Schuck P; Satterfield W; Moss B; Purcell R
J Virol; 2007 Sep; 81(17):8989-95. PubMed ID: 17581986
[TBL] [Abstract][Full Text] [Related]
2. Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.
Chen Z; Earl P; Americo J; Damon I; Smith SK; Zhou YH; Yu F; Sebrell A; Emerson S; Cohen G; Eisenberg RJ; Svitel J; Schuck P; Satterfield W; Moss B; Purcell R
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1882-7. PubMed ID: 16436502
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread.
He Y; Wang Y; Struble EB; Zhang P; Chowdhury S; Reed JL; Kennedy M; Scott DE; Fisher RW
Virol J; 2012 Sep; 9():217. PubMed ID: 23006741
[TBL] [Abstract][Full Text] [Related]
4. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
Paran N; Lustig S; Zvi A; Erez N; Israely T; Melamed S; Politi B; Ben-Nathan D; Schneider P; Lachmi B; Israeli O; Stein D; Levin R; Olshevsky U
Virol J; 2013 Jul; 10():229. PubMed ID: 23842430
[TBL] [Abstract][Full Text] [Related]
5. An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies.
Xu C; Meng X; Yan B; Crotty S; Deng J; Xiang Y
Virology; 2011 Sep; 418(1):67-73. PubMed ID: 21810533
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.
Golden JW; Hooper JW
Virology; 2008 Jul; 377(1):19-29. PubMed ID: 18482742
[TBL] [Abstract][Full Text] [Related]
7. Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6.
Aldaz-Carroll L; Xiao Y; Whitbeck JC; de Leon MP; Lou H; Kim M; Yu J; Reinherz EL; Isaacs SN; Eisenberg RJ; Cohen GH
J Virol; 2007 Aug; 81(15):8131-9. PubMed ID: 17522205
[TBL] [Abstract][Full Text] [Related]
8. Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein.
Kaever T; Meng X; Matho MH; Schlossman A; Li S; Sela-Culang I; Ofran Y; Buller M; Crump RW; Parker S; Frazier A; Crotty S; Zajonc DM; Peters B; Xiang Y
J Virol; 2014 Oct; 88(19):11339-55. PubMed ID: 25031354
[TBL] [Abstract][Full Text] [Related]
9. Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge.
Lustig S; Fogg C; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
J Virol; 2005 Nov; 79(21):13454-62. PubMed ID: 16227266
[TBL] [Abstract][Full Text] [Related]
10. Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.
Golden JW; Zaitseva M; Kapnick S; Fisher RW; Mikolajczyk MG; Ballantyne J; Golding H; Hooper JW
Virol J; 2011 Sep; 8():441. PubMed ID: 21933385
[TBL] [Abstract][Full Text] [Related]
11. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.
Kaever T; Matho MH; Meng X; Crickard L; Schlossman A; Xiang Y; Crotty S; Peters B; Zajonc DM
J Virol; 2016 May; 90(9):4334-4345. PubMed ID: 26889021
[TBL] [Abstract][Full Text] [Related]
12. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588
[TBL] [Abstract][Full Text] [Related]
13. Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.
Matho MH; Schlossman A; Meng X; Benhnia MR; Kaever T; Buller M; Doronin K; Parker S; Peters B; Crotty S; Xiang Y; Zajonc DM
PLoS Pathog; 2015 Sep; 11(9):e1005148. PubMed ID: 26325270
[TBL] [Abstract][Full Text] [Related]
14. Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo.
Goncalvez AP; Chien CH; Tubthong K; Gorshkova I; Roll C; Donau O; Schuck P; Yoksan S; Wang SD; Purcell RH; Lai CJ
J Virol; 2008 Jul; 82(14):7009-21. PubMed ID: 18480437
[TBL] [Abstract][Full Text] [Related]
15. Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis.
Chen Z; Sosnovtsev SV; Bok K; Parra GI; Makiya M; Agulto L; Green KY; Purcell RH
J Virol; 2013 Sep; 87(17):9547-57. PubMed ID: 23785216
[TBL] [Abstract][Full Text] [Related]
16. Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine.
Benhnia MR; Maybeno M; Blum D; Aguilar-Sino R; Matho M; Meng X; Head S; Felgner PL; Zajonc DM; Koriazova L; Kato S; Burton DR; Xiang Y; Crowe JE; Peters B; Crotty S
J Virol; 2013 Feb; 87(3):1569-85. PubMed ID: 23152530
[TBL] [Abstract][Full Text] [Related]
17. Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.
Benhnia MR; McCausland MM; Laudenslager J; Granger SW; Rickert S; Koriazova L; Tahara T; Kubo RT; Kato S; Crotty S
J Virol; 2009 Dec; 83(23):12355-67. PubMed ID: 19793826
[TBL] [Abstract][Full Text] [Related]
18. Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.
Men R; Yamashiro T; Goncalvez AP; Wernly C; Schofield DJ; Emerson SU; Purcell RH; Lai CJ
J Virol; 2004 May; 78(9):4665-74. PubMed ID: 15078949
[TBL] [Abstract][Full Text] [Related]
19. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP
PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.
McCausland MM; Benhnia MR; Crickard L; Laudenslager J; Granger SW; Tahara T; Kubo R; Koriazova L; Kato S; Crotty S
Antivir Ther; 2010; 15(4):661-75. PubMed ID: 20587859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
